/ /

  • linkedin
  • Increase Font
  • Sharebar

    Consensus: marijuana has no role in glaucoma management

    ChicagoAs more state legislatures are relaxing anti-marijuana laws, physicians are being put in the middle by patients requesting prescriptions or authorizations for its use for medical needs, said Marc F. Lieberman, MD.

    Discussing the topic of medicinal cannabis for glaucoma, Dr. Leiberman explained that the consistent conclusion—based on years of study—is that marijuana is less effective than currently available topical glaucoma therapies and is inappropriate for glaucoma management.

    In case you missed it: OCULUS Surgical launches ImproVue ophthalmic lubricant drops

    “At the end of 2014, there is broad consensus from the FDA, the National Eye Institute, and ophthalmological societies . . . that there is no current role for use of cannabis agents in the management of glaucoma,” said Dr. Lieberman, clinical professor of ophthalmology, University of California San Francisco. “I encourage all of us as ophthalmologists to proclaim clearly there is no therapeutically useful reason for marijuana to be used as management for chronic IOP reduction.

    “In my personal practice, I educate my patients, I refrain from prescribing marijuana, and I try to do no harm,” he continued.

    New Call-to-action


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • Dr. Richard Bensinger
      Marijuana use was the focus of political manipulation and jockeying for political advantage resulting in severely exaggerated "harm" publicized to a generation who knew first hand of these lies about the product. That generation is now adult and more, and is working to eliminate these laws which did little good and ruined lives. Studies of marijuana in that era were disappointing let alone requiring smoking as a drug delivery system. Current marijuana, with focused breeding, has let loose a generation of much higher potency. If there is some value in glaucoma, the new marijuana could be studied although drug companies will not touch it due to fear of legal constraints and possible inability to patent the results. This will require an NIH study or perhaps a small start-up pharma company to investigate any potential further.
      It wont probably end there. Medical Marijuana ( getwhitepalm.com ) has been helpful to different kind of patients. It can basically serve as pain reliever to many illness too.


    View Results